Savara Inc. buy BiotechBee
Start price
07.04.24
/
50%
€4.36
Target price
31.10.25
€8.00
Performance (%)
-16.97%
End price
08.06.24
€3.62
Summary
This prediction ended on 08.06.24 with a price of €3.62. The prediction for Savara Inc. disappointed with a performance of -16.97%. BiotechBee has a follow-up prediction for Savara Inc. where he still thinks Savara Inc. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Savara Inc. | -4.505% | -4.505% |
iShares Core DAX® | -3.033% | -0.013% |
iShares Nasdaq 100 | -3.554% | -2.546% |
iShares Nikkei 225® | -3.938% | 2.183% |
iShares S&P 500 | -1.517% | -0.882% |
According to BiotechBee what are the pros and cons of Savara Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Savara Inc. diskutieren
Buy mit Kursziel 8,0
In the thread Trading Savara Inc.
Buy beendet
Current prediction by BiotechBee for Savara Inc.
Savara Inc.
Start price
Target price
Perf. (%)
€3.68
22.06.24
22.06.24
€5.00
28.02.26
28.02.26
11.96%
19.07.24
19.07.24
Could be very worthwhile Investment >20% year